AB1090 EFFICACY OF UPADACITINIB IN PATIENTS WITH ...

UPA15 treatment was associated with long-term improvements in pain, disability, work productivity, disease activity, and quality of life in patients with PsA

Efficacy and safety of upadacitinib in patients with active ankylosing ...

Conclusions: Upadacitinib efficacy, including very low rates of radiographic progression, was demonstrated through 104 weeks in treatment- ...

Abstract - Annals of the Rheumatic Diseases

Objectives The objective of this post-hoc analysis is to assess the efficacy of upadacitinib (UPA), a Janus kinase inhibitor, on axial symptoms in patients ...

Efficacy and safety of upadacitinib in patients with ankylosing ...

Background: Upadacitinib, a Janus kinase inhibitor, has demonstrated efficacy and an acceptable safety profile in patients with ankylosing ...

Efficacy and safety of upadacitinib in patients with ankylosing ...

Upadacitinib, a Janus kinase inhibitor, has demonstrated efficacy and an acceptable safety profile in patients with ankylosing spondylitis ...

Bill Text - AB-1090 County officers - California Legislative Information

AB 1090 County officers: sheriffs ... The people of the State of California do enact as follows: SECTION 1 ...